Skip to main content
SpringerLink
Log in

Pathology associated with sporadic Parkinson’s disease — where does it end?

  • Conference paper
Parkinson’s Disease and Related Disorders

Part of the book series: Journal of Neural Transmission. Supplementa ((NEURALTRANS,volume 70))

Summary

Parkinson’s disease (PD) is a multisystem disorder in which predisposed neuronal types in specific regions of the human peripheral, enteric, and central nervous systems become progressively involved. A staging procedure for the PD-related inclusion body pathology (i.e., Lewy neurites and Lewy bodies) in the brain proposes that the pathological process begins at two sites and progresses in a topographically predictable sequence in 6 stages. During stages 1–2, the inclusion body pathology remains confined to the medulla oblongata, pontine tegmentum, and anterior olfactory structures. In stages 3–4, the basal mid- and forebrain become the focus of the pathology and the illness reaches its symptomatic phase. In the final stages 5–6, the pathological process is seen in the association areas and primary fields of the neocortex. To date, we have staged a total of 301 autopsy cases, including 106 cases with incidental pathology and 176 clinically diagnosed PD cases. In addition, 163 age-matched controls were examined. 19 of the 301 cases with PD-related pathology displayed a pathological distribution pattern of Lewy neurites and Lewy bodies that diverged from the staging scheme described above. In these cases, olfactory structures and the amygdala were predominantly involved in the virtual absence of brain stem pathology. Most of the divergent cases (17/19) had advanced concomitant Alzheimer’s disease-related neurofibrillary changes (stages IV-VI).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbott RD, Petrovitch H, White LR et al. (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57: 456–462

    PubMed  CAS  Google Scholar 

  • Ahlskog JE (2005) Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson’s disease. Mov Disord 20: 271–282

    Article  PubMed  Google Scholar 

  • Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59: 102–112

    Article  PubMed  Google Scholar 

  • Arai A, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y (2001) Alpha-synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation. Brain Res 888: 287–296

    Article  PubMed  CAS  Google Scholar 

  • Braak H (1980) Architectonics of the human telencephalic cortex. Springer, Berlin Heidelberg, pp 1–147

    Google Scholar 

  • Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15: 6–31

    Article  PubMed  CAS  Google Scholar 

  • Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol 88:493–500

    PubMed  CAS  Google Scholar 

  • Braak H, Braak E, Yilmazer D, Schultz C, Bohl J (1995) Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam, pp 14–19 (Biomedical Health Research, vol 10)

    Google Scholar 

  • Braak H, Del Tredici K (2004) Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 25:19–23

    Article  PubMed  CAS  Google Scholar 

  • Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003a) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211

    Article  PubMed  Google Scholar 

  • Braak H, Rüb U, Del Tredici K (2003b) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110: 517–536

    Article  PubMed  CAS  Google Scholar 

  • Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318: 121–134

    Article  PubMed  Google Scholar 

  • Braak H, Rüb U, Jansen Steur ENH, Del Tredici K, de Vos RAI (2005) Cognitive status correlates with neuropathological stage in Parkinson disease. Neurology 64: 1404–1410

    PubMed  CAS  Google Scholar 

  • Brooks DJ (2000) Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease. J Neurol 247[Suppl 2]:11–18

    Google Scholar 

  • Del Tredici K, Braak H (2004) Idiopathic Parkinson’s disease: staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C (eds) Molecular mechanisms in Parkinson’s disease. Landes Bioscience, Georgetown, TX, pp 1–32

    Google Scholar 

  • Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426

    PubMed  Google Scholar 

  • Dickson DW (1998) Aging in the central nervous system. In: Markesbery WR (ed) Neuropathology of dementing disorders. Arnold, London New York, pp 56–88

    Google Scholar 

  • Doty RL (2001) Olfaction. Ann Rev Psych 52:423–452

    Article  CAS  Google Scholar 

  • Forno LS (1969) Concentric hyaline intraneuronal inclusions of Lewy body type in the brain of elderly persons (50 incidental cases): relationship to parkinsonism. J Am Geriatr Soc 17: 557–575

    PubMed  CAS  Google Scholar 

  • Galvin JE, Lee VMY, Trojanowski JQ (2001) Synucleinopathies. Clinical and pathological implications. Arch Neurol 58: 186–190

    Article  PubMed  CAS  Google Scholar 

  • Geddes JW (2005) α-Synuclein: a potent inducer of tau pathology. Exp Neurol 192: 244–250

    Article  PubMed  CAS  Google Scholar 

  • Goedert M (2001) The significance of tau and α-synuclein inclusions in neurodegenerative diseases. Curr Opin Genet Dev 11: 343–351

    Article  PubMed  CAS  Google Scholar 

  • Hamilton RL (2000) Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol 10: 378–384

    Article  PubMed  CAS  Google Scholar 

  • Hawkes CH (2003) Olfaction in neurodegenerative disorder. Mov Disord 18: 364–372

    Article  PubMed  Google Scholar 

  • Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson’s disease a primary olfactory disorder? Q J Med 92: 473–480

    CAS  Google Scholar 

  • Hopkins DA, Bieger D, de Vente J, Steinbusch HWM (1996) Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Progr Brain Res 107: 79–96

    CAS  Google Scholar 

  • Huang XF, Törk I, Paxinos G (1993) Dorsal motor nucleus of the vagus nerve: a cyto-and chemoarch-itectonic study in the human. J Comp Neurol 330:158–182

    Article  PubMed  CAS  Google Scholar 

  • Jellinger KA (2003a) Neuropathological spectrum of synucleinopathies. Mov Disord 18[Suppl 6]:2–12

    Article  Google Scholar 

  • Jellinger KA (2003b) Alpha-synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution — a pilot study. Acta Neuropathol 106: 191–201

    Article  PubMed  Google Scholar 

  • Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111: 1219–1235

    Article  PubMed  CAS  Google Scholar 

  • Jellinger KA, Mizuno Y (2003) Parkinson’s disease. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 159–187

    Google Scholar 

  • Koller WC, Langston JW, Hubble JP et al. (1991) Does a long preclinical period occur in Parkinson’s disease? Neurology 41[Suppl 2]: 8–13

    PubMed  CAS  Google Scholar 

  • Kotzbauer PT, Trojanowski JQ, Lee VMY (2001) Lewy body pathology in Alzheimer’s disease. J Mol Neurosci 17: 225–232

    Article  PubMed  CAS  Google Scholar 

  • Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62: 1241–1253

    PubMed  CAS  Google Scholar 

  • Lang AE, Obeso JA (2004) Challenges in Parkinson’s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3: 309–316

    Article  PubMed  Google Scholar 

  • Lantos PL, Quinn N (2003) Multiple sytem atrophy. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 203–214

    Google Scholar 

  • Lowe J (1994) Lewy bodies. In: Calne DP (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 51–69

    Google Scholar 

  • Mesholam RL, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease. A meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol 55: 84–90

    Article  PubMed  CAS  Google Scholar 

  • Mikolaenko I, Pletnikova O, Kawas CH et al. (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol 64: 156–162

    PubMed  CAS  Google Scholar 

  • Morrish PK, Rakashi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with (18F)dopa PET. J Neurol Neurosurg Psychiatry 64: 314–319

    Article  PubMed  CAS  Google Scholar 

  • Neumann M, Müller V, Kretschmar HA, Haass C, Kahle PJ (2004) Regional distribution of proteinase-K a-synuclein correlates with Lewy body disease stage. J Neuropathol Exp Neurol 63: 1225–1235

    PubMed  CAS  Google Scholar 

  • Pankratz N, Foroud T (2004) Genetics of Parkinson disease. Neurotox 2: 235–242

    Google Scholar 

  • Parkinnen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) α-Synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57: 82–91

    Article  CAS  Google Scholar 

  • Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10: 283–287

    Article  PubMed  CAS  Google Scholar 

  • Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56: 173–181

    Article  PubMed  Google Scholar 

  • Rachakonda V, Pan TH, Le WD (2004) Biomarkers of neurodegenerative disorders: how good are they? Cell Res 14: 349–360

    Article  Google Scholar 

  • Saito Y, Kawashima A, Ruberu NN et al. (2003) Accumulation of phosphorylated α-synuclein in aging human brain. J Neuropathol Exp Neurol 62: 644–654

    PubMed  CAS  Google Scholar 

  • Saito Y, Ruberu NN, Sawabe M et al. (2004) Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 63: 742–749

    PubMed  Google Scholar 

  • Sawle GV (1993) The detection of preclinical Parkinson’s disease: what is the role of positron emission tomography? Mov Disord 8: 271–277

    Article  PubMed  CAS  Google Scholar 

  • Stiasny-Kolster K, Doerr Y, Möller JC et al. (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137

    Article  PubMed  CAS  Google Scholar 

  • Takahashi H, Wakabayashi K (2001) The cellular pathology of Parkinson’s disease. Neuropathology 21: 315–322

    Article  PubMed  CAS  Google Scholar 

  • Takahashi H, Wakabayashi K (2005) Controversy: is Parkinson’s disease a single disease entity? Yes. Parkinsonism Rel Disord 11: 31–37

    Article  Google Scholar 

  • Thal DR, Del Tredici K, Braak H (2004) Neurodegeneration in normal brain aging and disease. Sci Aging Knowledge Environ 23: 1–13

    Google Scholar 

  • Tissingh G, Berendse HW, Bergmans P et al. (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16: 41–46

    Article  PubMed  CAS  Google Scholar 

  • Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79: 581–583

    Article  PubMed  CAS  Google Scholar 

  • Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC (2000) Preclinical (premotor) Parkinson’s disease. J Neurol 247[Suppl 2]: 103–109

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Clinical Neuroanatomy, J.W. Goethe University, Theodor Stern Kai 7, 60590, Frankfurt/Main, Germany

    H. Braak M.D., C. M. Müller, U. Rüb & K. Del Tredici

  2. Department of Biomathematics, J.W. Goethe University, Frankfurt/Main, Germany

    H. Ackermann

  3. Institute for Forensic Medicine, J.W. Goethe University, Frankfurt/Main, Germany

    H. Bratzke

  4. Laboratorium Pathologie Oost Nederland, Enschede, The Netherlands

    R. A. I. de Vos

Authors
  1. H. Braak M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. M. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Rüb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Ackermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Bratzke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. A. I. de Vos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Del Tredici
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Würzburg, Germany

    P. Riederer  & M. Gerlach  & 

  2. Universitätsklinikum der TU Dresden, Dresden, Germany

    H. Reichmann

  3. Israel Institute of Technology, Haifa, Israel

    M. B. H. Youdim

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag

About this paper

Cite this paper

Braak, H. et al. (2006). Pathology associated with sporadic Parkinson’s disease — where does it end?. In: Riederer, P., Reichmann, H., Youdim, M.B.H., Gerlach, M. (eds) Parkinson’s Disease and Related Disorders. Journal of Neural Transmission. Supplementa, vol 70. Springer, Vienna . https://doi.org/10.1007/978-3-211-45295-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-45295-0_15

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-28927-3

  • Online ISBN: 978-3-211-45295-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation